Andrew J. Dalley

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

Jason A. Roberts, Carl M. J. Kirkpatrick, Michael S. Roberts et al. · Journal of Antimicrobial Chemotherapy · 2009 · 347 citations

Epithelial to mesenchymal transition (EMT) biomarkers – E-cadherin, beta-catenin, APC and Vimentin – in oral squamous cell carcinogenesis and transformation

S.Y. Chaw, Ahmad Abdul Majeed, Andrew J. Dalley et al. · Oral Oncology · 2012 · 308 citations

Epithelial-mesenchymal Transition, Oncology, Medicine +12

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

Jason A. Roberts, Carl M. J. Kirkpatrick, Michael S. Roberts et al. · International Journal of Antimicrobial Agents · 2009 · 192 citations

Ill Patients, Intermittent Dosing, Acute Care +7

Piperacillin penetration into tissue of critically ill patients with sepsis—Bolus versus continuous administration?

Jason A. Roberts, Michael S. Roberts, Thomas A. Robertson et al. · Critical Care Medicine · 2009 · 180 citations

The requirement for basement membrane antigens in the production of human epidermal/dermal composites in vitro

RALSTON, LAYTON, Andrew J. Dalley et al. · British Journal of Dermatology · 1999 · 107 citations

Tissue Engineering, Engineering, Immunology +17